Amkor Technology reports after the close on July 27 with the stock down 30% over the past month, though it has clawed back roughly 4% this week to $65.33 — and the options market is showing a modest but notable tilt toward caution heading into the release.
The put/call ratio has edged up to 0.65, about 1.2 standard deviations above its 20-day average of 0.60. That's not an extreme reading — the 52-week range runs from 0.09 to 5.03 — but the direction of travel matters. The PCR has drifted higher over the past two weeks, a pattern consistent with investors quietly adding downside protection after the sharp monthly drawdown. Borrow conditions offer no additional pressure signal: availability remains extraordinarily loose at over 3,300%, and the cost to borrow has actually fallen 41% over the past month to just 0.28%. Short interest at 3.6% of the float is modest and barely changed on the week. The positioning story here is defensive options, not an aggressive short thesis.
The analyst picture, covered in depth in the previous note published July 22, has not materially shifted. B. Riley cut its target to $75 from $90 that same day while holding Neutral — the most telling pre-earnings move. Goldman Sachs and Morgan Stanley sit at Neutral and Equal-Weight with targets in the $65–$69 range. JPMorgan holds Overweight at $65. Needham remains the lone bull at $90. The consensus mean of roughly $78 implies meaningful upside from here, but the distribution — mostly neutral with one outlier — still reads cautious rather than constructive. Bulls focus on Amkor's advanced packaging exposure to AI data center buildout and its Arizona facility investment. Bears flag reliance on foreign revenue and potential softness in the PC market as offsets to any AI-driven strength.
Earnings history adds context. The last three prints all produced negative one-day reactions: the most recent quarter in late April saw the stock fall roughly 8.6% on the day and extend losses to around 9% over the following five days. The quarter before that delivered a smaller one-day drop of 1.9% but a five-day loss of 6.8%. The pattern is consistent: post-earnings selling has been the norm. One notable ownership data point — the CFO sold shares twice in the past six weeks, most recently on July 14, and the General Counsel sold twice in the same period. The trades are small in absolute terms and carry low significance scores, but the direction is uniformly one-way.
Sunday's print will test whether Amkor's AI and advanced packaging narrative is strong enough to break a streak of post-earnings selloffs — and whether a stock already down 30% on the month carries enough bad news in the price to absorb whatever guidance it delivers.
See the live data behind this article on ORTEX.
Open AMKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
